Pharmaceutical Sterility Testing Market: By Product (Kits and Reagents, Instruments, Services), By Test (Direct Inoculation, Membrane Filtration, Bioburden Testing, Bacterial Endotoxin Testing, Container Closure Integrity Testing, Antimicrobial Effectiveness Testing, Rapid Micro Test, Others), By Application (Pharmaceutical and Biological Manufacturing, Medical devices Manufacturing, Other Applications), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
The Pharmaceutical Sterility Testing market will see a robust CAGR of 8.7%, valued at USD 1.22 billion in 2021, and is expected to reach USD 3.06 billion by 2032.
Pharmaceutical Sterility Testing is the investigation of the microorganisms. Sterility test is conducted with the help of bacteriostatic and fungistatic testing. This test secures the antimicrobial property within the test subject that barricades the identification of microbial organisms. This test is performed under a clean environment as per the instructions or the membrane filtration methods using the isolator. In pharmaceutical manufacturing, Sterility testing is an essential process during the validation and sterilization process along with the release testing. In several industries, it is an important part of every sterilization, validation process that makes it a pivotal procedure in manufacturing industry. It is an extremely tough procedure that should be designed and executed with precision, which can be helpful in ruling out false positive results. In a clean room, planned testing should be carried out where there is minimal, or no chances of error seen.
Pharmaceutical Sterility Testing Market is expected to project a notable CAGR of 8.7%
The Pharmaceutical Sterility Testing market will see a robust CAGR of 8.7%, valued at USD 1.22 billion in 2021, and is expected to reach USD 3.06 billion by 2032. The Pharmaceutical Sterility Testing market is estimated to rise soon owing to the increase in demand for sterilized items. Even the growth media should be prepared accurately and tested to make sure that the microbial growth is as efficient as possible during sterility testing.
Kits and Reagent segment holds the largest market share
The global Pharmaceutical Sterility Testing Market is segmented based on the Product into Kits and Reagents, Instruments, Services. Kits and Reagent segment is dominating the market, and it is estimated to grow significantly. This increase is due to the availability of an extensive range of products that help in minimizing the false-positive results and the risk of false-negative. Sterility testing pumps also came into existence that aid in increasing safety & streamlining workflow, which are designed to fit into all the testing facilities seamlessly.
Membrane filtration segment holds the largest market share
The global Pharmaceutical Sterility Testing Market is segmented based on the Test into Direct Inoculation, Membrane Filtration, Bioburden Testing, Bacterial Endotoxin Testing, Container Closure Integrity Testing, Antimicrobial Effectiveness Testing, Rapid Micro Test, Others. Membrane filtration is dominating the market, owing to advancements of technology in membrane filtration operations and designs, which increase the efficiency of filtration and allows the processes to operate with less energy consumption and at a low temperature.
Expanding Research and Development in Life Sciences
The expanding research and development in life sciences, together with significant private and public financing, is a major growth driver that is expanding the market of Pharmaceutical Sterility Testing. New firms are involving in the market of kit testing since it provides a constant of revenue from the clients
Innovations In Pharmaceutical and Medical Field
The need for sterility tests will increase along with developments in the pharmaceutical and medical fields. The global biotechnology industry is booming, which will help the sterility testing market grow over the forecast period. Sterility testing has benefited from new technology advancements that have improved process efficiency, which will promote market expansion.
Stringent Government Regulations
The insufficiency of qualified sterility testing professionals and a rise in the unit price of sterility testing are obstructing the market growth due to strict government rules. Rigid regulatory frameworks, high levels of consolidation and a lengthy licensing procedure are significant hurdles to new market entrants.
Pacific Bio labs
Company Overview, Business Strategy, Key Product Offerings, Key Performance Indicators, Financial Performance, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Pharmaceutical Sterility Testing Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America had the highest share of market in pharmaceutical sterility testing. Increased investing in life sciences, favorable initiatives by the government, increment in the research & development activities of medical technology, biotechnology and pharmaceutical industries are the primary reason behind possessing the largest industry share. On contrary, the Asia-Pacific region is the fastest growing market for sterility testing during the forecasted period, which is mainly due to the increment in expenditure on life science research.
The pharmaceutical sterility testing industry emerged globally from the COVID-19. Pharmaceutical and biotechnology indstries were in a race to develop COVID-19 vaccine. Any product, injection or vaccine provided should undergo final product sterility testing to be approved safe. Rapid testing kits use resulted in the rise of pharmaceutical sterility testing industry. The regular use of these screening procedures during the pandemic period had a positive impact on growth of the Pharmaceutical Sterility Testing industry.
Pharmaceutical Sterility Testing Market Segments:
Pharmaceutical Sterility Testing Market Report Scope and Segmentation
Market size value in 2021
USD 1.22 billion
Revenue forecast in 2032
USD 3.06 billion
CAGR of 8.7% from 2022 to 2032
Base year for estimation
Revenue in USD billion and CAGR from 2022 to 2032
Revenue forecast, competitive landscape company ranking, growth factors, and trends
Test, Product, Application and Region
Europe, North America, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled
Pacific Bio labs, SOLVIAS AG, STERIS, Boston Analytical, Nelson Laboratories, LLC, Sartorius AG, Rapid Micro Biosystems, Inc., SGS SA, Laboratory Corporation of America Holding, Charles River Laboratories, Thermo Fisher Scientific, Inc., Almac Group, Pace Analytical and Other Prominent Players
Pharmaceutical Sterility Testing market size was estimated at USD 1.22 billion in 2021 and is expected to reach USD 3.06 billion by 2032.
Pharmaceutical Sterility Testing is the investigation of the microorganisms. Sterility test is conducted with the help of bacteriostatic and fungistatic testing.
Kits & Reagents and Membrane Filtration segment accounted for the largest Pharmaceutical Sterility Testing market share.
Key players: Pacific Bio labs, SOLVIAS AG, STERIS, Boston Analytical, Nelson Laboratories, LLC, Sartorius AG, Rapid Micro Biosystems, Inc., SGS SA, Laboratory Corporation of America Holding, Charles River Laboratories, Thermo Fisher Scientific, Inc., Almac Group, Pace Analytical and Other Prominent Players are the key players in the Pharmaceutical Sterility Testing market.
Expanding research and development in life sciences and innovations in pharmaceutical and medical field are the factors driving the Pharmaceutical Sterility Testing market.
Select License Type
US : +1 (716) 218-3733
UK : +44 (208) 1235555
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT